Boundless Bio, Inc.BOLDNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank54
3Y CAGR-46.7%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-46.7%/yr
Quarterly compound
Percentile
P54
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 0.86% |
| Q3 2025 | 13.81% |
| Q2 2025 | 18.59% |
| Q1 2025 | 6.64% |
| Q4 2024 | -17.31% |
| Q3 2024 | 18.29% |
| Q2 2024 | -2.92% |
| Q1 2024 | -35.00% |
| Q4 2023 | 4.13% |
| Q3 2023 | -11.93% |
| Q2 2023 | 9.93% |
| Q1 2023 | -18.73% |
| Q4 2022 | 5.71% |
| Q3 2022 | 0.00% |
| Q3 2019 | 12.13% |
| Q2 2019 | 3.31% |
| Q1 2019 | -48.23% |
| Q4 2018 | 9.72% |
| Q3 2018 | -35.11% |
| Q2 2018 | 5.04% |
| Q1 2018 | -7.43% |
| Q4 2017 | 0.37% |
| Q3 2017 | -42.85% |
| Q2 2017 | 28.70% |
| Q1 2017 | -79.81% |
| Q4 2016 | -25.41% |
| Q3 2016 | 0.00% |